Trial · NCT04145531
Participant flow40
How many started, completed or left each group, period by period.
1 to 20 of 40
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A | STARTED | Part A: JZP-458 IM 25 mg/m^2 (MWF) | 33 | |
| Part A | STARTED | Part A: JZP-458 IM 37.5 mg/m^2 (MWF) | 83 | |
| Part A | STARTED | Part A: JZP-458 IM 25 (MW)/50 mg/m^2 (F) | 51 | |
| Part A | STARTED | Part B: JZP-458 IV 25 (MW)/50 mg/m^2 (F) | 0 | |
| Part A | Safety Analysis Set | Part A: JZP-458 IM 25 mg/m^2 (MWF) | 33 | |
| Part A | Safety Analysis Set | Part A: JZP-458 IM 37.5 mg/m^2 (MWF) | 83 | |
| Part A | Safety Analysis Set | Part A: JZP-458 IM 25 (MW)/50 mg/m^2 (F) | 51 | |
| Part A | Safety Analysis Set | Part B: JZP-458 IV 25 (MW)/50 mg/m^2 (F) | 0 | |
| Part A | Efficacy Analysis Set | Part A: JZP-458 IM 25 mg/m^2 (MWF) | 32 | |
| Part A | Efficacy Analysis Set | Part A: JZP-458 IM 37.5 mg/m^2 (MWF) | 83 | |
| Part A | Efficacy Analysis Set | Part A: JZP-458 IM 25 (MW)/50 mg/m^2 (F) | 50 | |
| Part A | Efficacy Analysis Set | Part B: JZP-458 IV 25 (MW)/50 mg/m^2 (F) | 0 | |
| Part A | COMPLETED | Part A: JZP-458 IM 25 mg/m^2 (MWF) | 27 | |
| Part A | COMPLETED | Part A: JZP-458 IM 37.5 mg/m^2 (MWF) | 62 | |
| Part A | COMPLETED | Part A: JZP-458 IM 25 (MW)/50 mg/m^2 (F) | 39 | |
| Part A | COMPLETED | Part B: JZP-458 IV 25 (MW)/50 mg/m^2 (F) | 0 | |
| Part A | NOT COMPLETED | Part A: JZP-458 IM 25 mg/m^2 (MWF) | 6 | |
| Part A | NOT COMPLETED | Part A: JZP-458 IM 37.5 mg/m^2 (MWF) | 21 | |
| Part A | NOT COMPLETED | Part A: JZP-458 IM 25 (MW)/50 mg/m^2 (F) | 12 | |
| Part A | NOT COMPLETED | Part B: JZP-458 IV 25 (MW)/50 mg/m^2 (F) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04145531/flow